RT @CVIR_Journal: TBT: TACE monotherapy vs combined TACE–microwave ablation therapy for HCC tumors | https://t.co/9UeSoQizvb #IRad #MIIP ht…
TBT: TACE monotherapy vs combined TACE–microwave ablation therapy for HCC tumors | https://t.co/9UeSoQizvb #IRad #MIIP https://t.co/1p5FM2R9YB
RT @CVIR_Journal: Last chance to read free of charge (until 29 Oct) this year's CVIR Editors’ Medal winning article on chemoembolisation tr…
RT @CVIR_Journal: Last chance to read free of charge (until 29 Oct) this year's CVIR Editors’ Medal winning article on chemoembolisation tr…
Last chance to read free of charge (until 29 Oct) this year's CVIR Editors’ Medal winning article on chemoembolisation treatment in HCC! https://t.co/pc6EImkhZa #iRads #CIRSE2018 https://t.co/4N4TV0XBzx
RT @cirsesociety: This year's #CVIR Editors’ Medal was awarded to the Chinese research group Qi-Feng Chen, Zhen-Yu Jia, Zheng-Qiang Yang, W…
This year's #CVIR Editors’ Medal was awarded to the Chinese research group Qi-Feng Chen, Zhen-Yu Jia, Zheng-Qiang Yang, Wen-Long Fan and Hai-Bin Shi. Read their investigation on chemoembolisation free of charge! https://t.co/YgaBHzJvIt #CIRSEsociety #iRads
We are thrilled to announce that the CVIR Editors' Medal 2018 will be awarded to Qi-Feng Chen and Zhen-Yu Jia et al. at CIRSE 2018, in Lisbon. Congratulations! Read their outstanding article: https://t.co/n3NypFqjRQ #IRads #InterventionalRadiology #MIIP ht